Video

The Australian market is holding onto small gains on Friday, with the ASX 200 fading from this morning’s highs. Healthcare stocks are standing out as Cochlear received approval for the sale of new products in the US.

Wall Street started the trading session strongly after the US government reported that a record 4.8 million jobs were added in June after an upwardly revised 2.7 million gain in May. US President Donald Trump said the US economy is “roaring back.”

The Aussie sharemarket rose for a third day and hit a three-week high. All sectors improved. Afterpay, Nextdc, Xero, Ansell, Temple & Webster and Kogan all hit record highs.

The Aussie market is following the positive US lead, with the ASX 200 rising by ~1% at lunch. All sectors are improving with buy-now-pay-later companies continuing to lift strongly.

Sentiment was boosted by positive virus vaccine developments and better-than-expected US manufacturing data.

It was a solid start to the new financial year for local shares, lifting for a second successive day. Investors are still wary of rising COVID-19 infection rates but were comforted by better than expected Chinese manufacturing data.

The Aussie market is kicking off the new financial year, the way it finished the old, as the ASX 200 firms around midday. Improvements are broad based as investors focus on a lift in consumer confidence out of the US.

US sharemarkets rose on Tuesday as investors weighed better than expected economic data against virus and China trade concerns. Micron Technology shares rose 4.8% after a solid earnings report.

The Aussie market has closed out the financial year on a positive note with the ASX 200 lifting 83pts or 1.4% to 5897. Today’s improvement helped lift the index for a solid gain over the month and quarter.

The ASX 200 is rebounding from a sharp drop on Monday with the index jumping roughly 1.4% just after midday. Gains have been across the majority of sectors with energy and retailing names among some of the most improved while the health sector is underperforming.

Investors were encouraged by positive economic data. Shares in Boeing rose by 14.4%, driving the Dow Jones index higher, on news that the company had started flight testing a 737 MAX aircraft with the Federal Aviation Administration. The Dow Jones index gained 580 points or 2.3%. The S&P500 index rose by 1.5%. The Nasdaq index was higher by 117 points or 1.2%.

The ASX 200 has started the new week in the red with broad losses due to concerns over a new spike in COVID19 cases. The benchmark index ended the day down 89pts or 1.5% to 5,815 as all sectors closed in negative territory.

Investor worries over the spike in COVID-19 infection rates has led to some sharp selling on the Aussie market to start the week. Losses are heaviest among banking, energy and travel stocks.

Texas and Florida halted drinking at bars and Arizona reported a surge in COVID-19 infections. Bank shares fell 6.1% after the US Federal Reserve capped dividends and banned buybacks until September.

We continue to unearth small-cap companies as part of our Hidden Gems webinar series. Catch up on the most recent edition with presentations from Splitit Payments Ltd (ASX:SPT), Kazia Therapeutics (ASX: KZA), Memphasys (ASX: MEM), and Antisense Therapeutics Limited (ASX:ANP).

The Australian sharemarket bounced back from a 2.5% decline on Thursday with a 1.5% lift today. Gains from financials and miners helped push the market higher, while a lift in Dow Futures seemed to provide an additional boost this afternoon.

The Australian sharemarket is up 0.75%, following a much heftier 2.5% decline on Thursday. Strong improvements from the banks and miners are pushing stocks higher.

Regulation for the big US banks was rolled back. Shares of banks Wells Fargo (+4.8%), Goldman Sachs (+4.6%) and JPMorgan (+3.5%) advanced after regulators eased rules that will free up capital.

The Australian sharemarket’s losses accelerated this afternoon, with shares falling by 2.5% following losses across the board as COVID-19 continues to create concerns for the economy.

The Australian sharemarket is down by almost 2% on Thursday, with 11 of 12 sectors in negative territory. A record one-day increase in US COVID-19 cases, IMF downgrades and talk of further US tariffs is weighing heavily.

Psychedelic stocks on the charge in North America is creating opportunities for Australian investors. Peter Hunt, Founder, Mind Medicine Australia shares his insights at the ShareCafe Psychedelic Stocks Webinar.

US sharemarkets fell 2.0-2.5% on Wednesday on fears that a lift in virus cases in many states could see re-imposition of restrictions on travel and business operations. The Dow Jones index lost 710 points or 2.7%. The S&P500 index fell by 2.6%. The Nasdaq index was lower by 222 points or 2.2%.

The Australian sharemarket has managed to extend its winning streak to four days even though it was a choppy session. Gains from gold and healthcare stocks pushed the market higher.

The Australian market is slightly lower at lunch despite a better start which was putting local equities on a four-day winning streak. Weakness from the banks, energy and property stocks together with travel companies is weighing on our market.

US sharemarkets rose on Tuesday on assurances from President Trump about the US-China trade deal and speculation that the US Congress will seek additional stimulus to bolster the economy.

Afternoon trading was far calmer for the ASX 200 after comments earlier in the day from a top US trade advisor alluding to the US-China trade deal being ‘over’ sent shock waves through global markets. Once it was clarified that the deal remained intact, the benchmark index recovered to a modest gain.

It was a frenetic morning for markets including our own ASX with investors reacting initially to comments from the US Trump Administration that the trade deal with China was ‘over’. That has since been clarified with markets recovering after the comments were said to be taken out of context.

Investors continued to bet on the economic reopening and central bank support, despite a surge in new COVID-19 cases in the US South and Southwest. White House economic adviser Larry Kudlow told CNBC that there was no second wave of the pandemic.

It was another day of choppy trade as investors remain cautious of lifting COVID-19 infection rates in parts of the US, China and now Victoria. The ASX 200 swung between gains and losses before settling mostly flat, with a gain of just 2 points.

The Aussie market is recovering from a sharp drop on the open with the ASX 200 hovering around the flat line at midday. Concerns are lingering about a spike in new COVID19 cases in parts of the US, China and now Victoria.

Earlier in the session the Dow Jones index gained 371 points on Bloomberg reports that China plans to increase purchases of American farm goods following talks in Hawaii this week. But increasing concerns about record COVID-19 cases in Florida and Arizona pushed shares lower with Apple (- 0.6%) re-closing 11 US stores. Volatility was heightened as equity options and futures on indexes expired. The Dow Jones index closed lower by 208 points or 0.8%. The S&P500 index fell 0.6%. The Nasdaq index was up by just 3 points. For the week, the Dow Jones gained 1%, the S&P 500 rose by 1.8% and the Nasdaq was up 3.7%.

The Australian sharemarket rose by just 0.1% on Friday (up 1.2% this morning). Losses from the banks and miners held equities back in what was a solid week for shares (up 1.6%).